Skip to main content
Raymond Douglas, MD, Ophthalmology, Beverly Hills, CA

RaymondSDouglasMDPhD

Ophthalmology Beverly Hills, CA

Oculo-Plastic & Orbital Reconstructive Surgery

Associate Professor of Ophthalmology & Visual Sciences, University of Michigan Kellogg Eye Center

Dr. Douglas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Douglas' full profile

Already have an account?

  • Office

    9675 Brighton Way
    Ste 410
    Beverly Hills, CA 90210
    Phone+1 310-363-8757
    Fax+1 310-363-8758

Summary

  • Dr. Raymond Douglas is an oculoplastics specialist who sees patients at the University of Michigan Kellogg Eye Center in Ann Arbor. Dr. Douglas’ clinical practice focuses on orbital surgery, especially minimally invasive surgery, and decompressions for thyroid-associated eye disease. He also performs cosmetic facial surgeries including blepharoplasty, eyelid lift, midface lift, fillers for under-eye hollows, and Botox injections as well as post-cancer reconstruction including Mohs surgery.

    Dr. Douglas is well known for his clinical expertise and research on Graves’ eye disease and is the Director of Kellogg’s Thyroid Eye Disease Clinic. His research focuses on Graves' eye disease, autoimmune diseases of the orbit, and minimally invasive approaches to the orbit. To make an appointment, please call Kellogg’s Thyroid Eye Disease Clinic at 734-764-5106. To refer a patient, please visit www.kellogg.umich.edu/refer.

Education & Training

  • University of Pennsylvania Health System/Scheie Eye Institute
    University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 1999 - 2002
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • IL State Medical License
    IL State Medical License 2023 - 2026
  • FL State Medical License
    FL State Medical License 2023 - 2025
  • NV State Medical License
    NV State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2014 - 2025
  • MI State Medical License
    MI State Medical License 2008 - 2019
  • PA State Medical License
    PA State Medical License 1999 - 2002
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Teprotumumab for the Treatment of Active Thyroid Eye Disease  
    Raymond Douglas, MD, The New England Journal of Medicine
  • Objectively Measuring Observer Attention in Severe Thyroid‐Associated Orbitopathy: A 3D Study  
    Lisa E Ishii, Halley M Darrach, Andrew W Joseph, Raymond S Douglas, David Liao, Masaru Ishii, The Laryngoscope

Press Mentions

  • RVL Pharmaceuticals Announces That Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty Awards
    RVL Pharmaceuticals Announces That Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty AwardsApril 10th, 2023
  • Thrive Health Infusion Centers Launch for Thyroid Eye Disease in Tandem with Thyroid Awareness Month
    Thrive Health Infusion Centers Launch for Thyroid Eye Disease in Tandem with Thyroid Awareness MonthJanuary 25th, 2023
  • Teprotumumab May Be Effective in Thyroid Eye Disease with Less Inflammation
    Teprotumumab May Be Effective in Thyroid Eye Disease with Less InflammationNovember 15th, 2021
  • Join now to see all

Grant Support

  • The Role Of CD40+ Fibrocytes In Thyroid Associated OphthalmopathyNational Eye Institute2011–2012
  • Immune Activation Of FibroblastsNational Eye Institute2008
  • Immune Activation Of FibroblastsNational Eye Institute2004–2008

Professional Memberships